Treatment of warts in children with MMR vaccine
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Common warts
- Registration Number
- CTRI/2017/11/010344
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 165
Inclusion Criteria
1. Children and adolescents clinically diagnosed having untreated common warts
Exclusion Criteria
1. Children with apparent infection or immunosuppression, asthma, allergic disorders, meningitis or convulsions
2. Children who have received treatment for warts in preceding month
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical improvement was evaluated as complete, partial or no response at each visitTimepoint: Once a month after completion of treatment for 6 months
- Secondary Outcome Measures
Name Time Method Evaluation for adverse effect and recurrencesTimepoint: Once a month after last dose for 6 months